Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Long-Term Investments (2016 - 2025)

National Healthcare (NHC) has disclosed Long-Term Investments for 16 consecutive years, with $38.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Investments rose 38.94% year-over-year to $38.7 million, compared with a TTM value of $38.7 million through Dec 2025, up 38.94%, and an annual FY2025 reading of $38.7 million, up 38.94% over the prior year.
  • Long-Term Investments was $38.7 million for Q4 2025 at National Healthcare, up from $36.5 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $38.7 million in Q4 2025 and bottomed at $1.9 million in Q2 2021.
  • Average Long-Term Investments over 5 years is $15.4 million, with a median of $9.9 million recorded in 2023.
  • The sharpest move saw Long-Term Investments plummeted 95.04% in 2021, then skyrocketed 689.66% in 2023.
  • Year by year, Long-Term Investments stood at $2.0 million in 2021, then grew by 1.88% to $2.1 million in 2022, then surged by 689.66% to $16.3 million in 2023, then surged by 71.38% to $27.9 million in 2024, then skyrocketed by 38.94% to $38.7 million in 2025.
  • Business Quant data shows Long-Term Investments for NHC at $38.7 million in Q4 2025, $36.5 million in Q3 2025, and $36.7 million in Q2 2025.